Endocrine resistance in hormone receptor positive breast cancer–from mechanism to therapy

A Rani, J Stebbing, G Giamas, J Murphy - Frontiers in endocrinology, 2019 - frontiersin.org
The importance and role of the estrogen receptor (ER) pathway has been well-documented
in both breast cancer (BC) development and progression. The treatment of choice in women …

Getting Syk: spleen tyrosine kinase as a therapeutic target

RL Geahlen - Trends in pharmacological sciences, 2014 - cell.com
Spleen tyrosine kinase (Syk) is a cytoplasmic protein tyrosine kinase well known for its
ability to couple immune cell receptors to intracellular signaling pathways that regulate …

[HTML][HTML] Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer

MO Krisenko, RL Geahlen - … et Biophysica Acta (BBA)-Molecular Cell …, 2015 - Elsevier
SYK (spleen tyrosine kinase) is well-characterized in the immune system as an essential
enzyme required for signaling through multiple classes of immune recognition receptors. As …

In-depth analyses of kinase-dependent tyrosine phosphoproteomes based on metal ion-functionalized soluble nanopolymers

AB Iliuk, VA Martin, BM Alicie, RL Geahlen… - Molecular & cellular …, 2010 - ASBMB
The ability to obtain in-depth understanding of signaling networks in cells is a key objective
of systems biology research. Such ability depends largely on unbiased and reproducible …

Alternative splicing of SYK regulates mitosis and cell survival

P Prinos, D Garneau, JF Lucier, D Gendron… - Nature structural & …, 2011 - nature.com
Most human genes produce multiple mRNA isoforms through alternative splicing. However,
the biological relevance of most splice variants remains unclear. In this study, we evaluated …

The Syk tyrosine kinase: a new negative regulator in tumor growth and progression

PJ Coopman, SC Mueller - Cancer letters, 2006 - Elsevier
The spleen tyrosine kinase Syk was long thought to be a hematopoietic cell-specific
signaling molecule. Recent evidence demonstrated that it is also expressed by many non …

Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells

R Gioia, C Leroy, C Drullion, V Lagarde… - Blood, The Journal …, 2011 - ashpublications.org
In this study, we have addressed how Lyn kinase signaling mediates nilotinib-resistance by
quantitative phospho-proteomics using Stable Isotope Labeling with Amino acid in Cell …

Deregulated Syk inhibits differentiation and induces growth factor–independent proliferation of pre–B cells

T Wossning, S Herzog, F Köhler… - The Journal of …, 2006 - rupress.org
The nonreceptor protein spleen tyrosine kinase (Syk) is a key mediator of signal
transduction in a variety of cell types, including B lymphocytes. We show that deregulated …

Frequent Epigenetic Inactivation of Spleen Tyrosine Kinase Gene in Human Hepatocellular Carcinoma

Y Yuan, J Wang, J Li, L Wang, M Li, Z Yang… - Clinical cancer …, 2006 - AACR
Purpose: The aim of present study was to investigate the methylation and expression status
of spleen tyrosine kinase (SYK) in human hepatocellular carcinoma (HCC) and to evaluate …

[HTML][HTML] Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis

SH Shin, KH Lee, BH Kim, S Lee, HS Lee, JJ Jang… - Laboratory …, 2014 - Elsevier
Spleen tyrosine kinase (SYK) has predominantly been studied in hematopoietic cells, where
it is involved in immunoreceptor-mediated signaling. However, SYK expression has been …